Immuneering IMRX
NASDAQ IMRX
$4.07 +0.04 (+0.99%)
At close: Oct 2, 2026 · 4:00 PM EDT

Immuneering (IMRX) Return on Capital Employed [ROCE] (2021 - 2026)

Updated

Immuneering's Return on Capital Employed [ROCE] was -31.68% in Q2 2026, up 137.46 percentage points from -169.14% a year earlier but down 4.57 percentage points from the prior quarter.

Analysis

Immuneering (IMRX) Return on Capital Employed [ROCE] (2021 - 2026) Analysis & Trends

For FY2025, Return on Capital Employed [ROCE] at Immuneering came in at -44.89%, up 46.45 percentage points from FY2024.

  • Return on Capital Employed [ROCE] shows a four-year change of -9.93 percentage points (FY2021 to FY2025).
  • In earlier years, Return on Capital Employed [ROCE] was -91.34% in FY2024 (-35.51 pp), -55.83% in FY2023 (-17.91 pp), -37.91% in FY2022 (-2.95 pp) and -34.96% in FY2021.
  • Quarterly Return on Capital Employed [ROCE] has moved between -169.14% (Q2 2025) and -21.21% (Q4 2021) over five years.
  • Compared with a year earlier, Return on Capital Employed [ROCE] has increased for four straight quarters, with an average year-over-year change of +14.86 percentage points over the last eight quarters.
  • The best year-over-year quarter for Return on Capital Employed [ROCE] over five years was Q2 2026 (a gain of 137.46 percentage points); the worst was Q2 2025 (a drop of 89.32 percentage points).
  • Per Business Quant data, IMRX's Return on Capital Employed [ROCE] in the three quarters before Q2 2026 was -27.12% (Q1 2026), -26.22% (Q4 2025) and -48.99% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn 46.74%
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn 17.83%
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn 17.92%
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn 6.28%
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn 19.32%
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn 9.54%
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn 16.66%
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn -5.97%
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn 11.86%
10 Immuneering 260.73 Mn 260.73 Mn - -31.68%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -31.68%
Mar 31, 2026 -27.12%
Dec 31, 2025 -26.22%
Sep 30, 2025 -48.99%
Jun 30, 2025 -169.14%
Mar 31, 2025 -137.86%
Dec 31, 2024 -120.59%
Sep 30, 2024 -93.80%
Jun 30, 2024 -79.82%
Mar 31, 2024 -65.54%
Dec 31, 2023 -58.19%
Sep 30, 2023 -49.31%
Jun 30, 2023 -49.95%
Mar 31, 2023 -48.85%
Dec 31, 2022 -43.13%
Sep 30, 2022 -37.42%
Jun 30, 2022 -30.83%
Mar 31, 2022 -26.03%
Dec 31, 2021 -21.21%
Sep 30, 2021 -27.70%
API Access

Immuneering Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=IMRX&period=max&api_key=YOUR_API_KEY